Amin M M, Ban T A, Pecknold J C, Klingner A
J Int Med Res. 1977;5 Suppl 5:33-7.
In a comparative study of three treatment regimens in patients with obsessive-compulsive or phobic manifestations, the most favourable therapeutic findings were seen in the clomipramine (Anafranil, Geigy Pharmaceuticals) plus behaviour therapy group and the least favourable therapeutic findings in the clomipramine plus simulated behaviour therapy group. The findings that a combination of behaviour therapy and clomipramine results in more favourable therapeutic changes than either of the two treatments alone is in line with reported studies in the literature.
在一项针对有强迫或恐惧表现患者的三种治疗方案的比较研究中，最有利的治疗结果出现在氯米帕明（安拿芬尼，嘉基制药公司）加行为治疗组，而最不利的治疗结果出现在氯米帕明加模拟行为治疗组。行为治疗与氯米帕明联合使用比单独使用这两种治疗方法中的任何一种都能带来更有利的治疗变化，这一结果与文献中报道的研究一致。
